Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis
- PMID: 22641138
- DOI: 10.1038/nrrheum.2012.80
Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis
Abstract
During osteoarthritis (OA), angiogenesis is increased in the synovium, osteophytes and menisci and leads to ossification in osteophytes and the deep layers of articular cartilage. Angiogenic and antiangiogenic factors might both be upregulated in the osteoarthritic joint; however, vascular growth predominates, and the articular cartilage loses its resistance to vascularization. In addition, blood vessel growth is increased at--and disrupts--the osteochondral junction. Angiogenesis in this location is dependent on the creation of channels from subchondral bone spaces into noncalcified articular cartilage. Inflammation drives synovial angiogenesis through macrophage activation. Blood vessel and nerve growth are linked by common pathways that involve the release of proangiogenic factors, such as vascular endothelial growth factor, β-nerve growth factor and neuropeptides. Proangiogenic factors might also stimulate nerve growth, and molecules produced by vascular cells could both stimulate and guide nerve growth. As sensory nerves grow along new blood vessels in osteoarthritic joints, they eventually penetrate noncalcified articular cartilage, osteophytes and the inner regions of menisci. Angiogenesis could, therefore, contribute to structural damage and pain in OA and provide potential targets for new treatments.
Similar articles
-
Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis.Rheumatology (Oxford). 2010 Oct;49(10):1852-61. doi: 10.1093/rheumatology/keq188. Epub 2010 Jun 26. Rheumatology (Oxford). 2010. PMID: 20581375 Free PMC article.
-
Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis.Osteoarthritis Cartilage. 2007 Jul;15(7):743-51. doi: 10.1016/j.joca.2007.01.020. Epub 2007 Mar 21. Osteoarthritis Cartilage. 2007. PMID: 17376709
-
Dkk-1 promotes angiogenic responses and cartilage matrix proteinase secretion in synovial fibroblasts from osteoarthritic joints.Arthritis Rheum. 2012 Oct;64(10):3267-77. doi: 10.1002/art.34602. Arthritis Rheum. 2012. PMID: 22736200
-
Osteochondral alterations in osteoarthritis.Bone. 2012 Aug;51(2):204-11. doi: 10.1016/j.bone.2011.10.010. Epub 2011 Oct 17. Bone. 2012. PMID: 22023932 Review.
-
Osteochondral plate angiogenesis: a new treatment target in osteoarthritis.Joint Bone Spine. 2011 Mar;78(2):144-9. doi: 10.1016/j.jbspin.2010.07.001. Epub 2010 Sep 18. Joint Bone Spine. 2011. PMID: 20851653
Cited by
-
Vascular Endothelial Growth Factor Biology and Its Potential as a Therapeutic Target in Rheumatic Diseases.Int J Mol Sci. 2021 May 20;22(10):5387. doi: 10.3390/ijms22105387. Int J Mol Sci. 2021. PMID: 34065409 Free PMC article. Review.
-
Two reactive behaviors of chondrocytes in an IL-1β-induced inflammatory environment revealed by the single-cell RNA sequencing.Aging (Albany NY). 2021 Apr 20;13(8):11646-11664. doi: 10.18632/aging.202857. Epub 2021 Apr 20. Aging (Albany NY). 2021. PMID: 33879632 Free PMC article.
-
Baicalein alleviates osteoarthritis by protecting subchondral bone, inhibiting angiogenesis and synovial proliferation.J Cell Mol Med. 2021 Jun;25(11):5283-5294. doi: 10.1111/jcmm.16538. Epub 2021 May 3. J Cell Mol Med. 2021. PMID: 33939310 Free PMC article.
-
Combined genicular artery embolization and genicular nerve block to treat chronic pain following total knee arthroplasty.CVIR Endovasc. 2024 Jan 3;7(1):4. doi: 10.1186/s42155-023-00409-3. CVIR Endovasc. 2024. PMID: 38170403 Free PMC article.
-
Pathological mechanism of chondrocytes and the surrounding environment during osteoarthritis of temporomandibular joint.J Cell Mol Med. 2021 Jun;25(11):4902-4911. doi: 10.1111/jcmm.16514. Epub 2021 May 5. J Cell Mol Med. 2021. PMID: 33949768 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials